Yusof PDF 15Kb

Predicting severe infection in repeat cycles of rituximab and effects of hypogammaglobulinaemia for the treatment of rheumatic and musculoskeletal diseases.

Md Yuzaiful Md Yusof^1,2, Edward M Vital^1,2,Damien McElvenny³, Elizabeth M A Hensor^1,2, Sudipto Das^1,2, Shouvik Dass¹, Andy C Rawstron⁴, Maya H Buch^1,2, Paul Emery^1,2, Sinisa Savic^1,2

1. Leeds Institute of Rheumatic and Musculoskeletal Medicine, University of Leeds, UK. 2. NIHR Leeds Biomedical Research Centre, Leeds Teaching Hospitals, NHS Trust, UK. 3. Institute of Population Health, University of Manchester, UK. 4. Haematological Malignancy Diagnostic Service, Leeds Teaching Hospitals NHS Trust, UK